Because human embryonic stem (hES) cells can differentiate into virtually any cell type in the human body, these cells hold promise for regenerative medicine. The genetic manipulation of hES cells will enhance our understanding of genes involved in early development and will accelerate their potential use and application for regenerative medicine. The objective of this study was to increase the transfection efficiency of plasmid DNA into hES cells by modifying a standard reverse transfection (RT) protocol of lipofection. We hypothesized that immobilization of plasmid DNA in extracellular matrix would be a more efficient method for plasmid transfer due to the affinity of hES cells for substrates such as Matrigel and to the prolonged exposure...
Copyright © 2010 C. Madeira et al. This is an open access article distributed under the Creative Com...
Objective: Genetic modification of human embryonic stem cells (hESCs) is critical for their extensi...
Embryonic stem (ES) cells are derived from the inner cell mass of blastocysts, an early-stage of pre...
Abstract — Stem/progenitor cells hold a great promise for application in several therapies due to th...
[[abstract]]Embryonic stem (ES) cells are considered to have potentials for tissue regeneration and ...
The ability of embryonic stem cells and adult stem cells to differentiate into specific cell types h...
It is widely recognized that gain- and loss-of-function approaches are essential for understanding t...
Embryonic stem (ES) cells are considered to have potentials for tissue regeneration and treatment of...
Nucleic acids have clear clinical potential for gene therapy. Plasmid DNA (pDNA) was the first nucle...
Technologies designed to allow manipulation and modification of human embryonic stem (hES) cells are...
Electroporation has been the method of election for transfection of murine embryonic stem cells for ...
Ex vivo gene therapy offers enormous potential for cell-based therapies, however, cumbersome in vitr...
Low efficiency of transfection limits the ability to genetically manipulate human embryonic stem cel...
AbstractUsing the lipofection reagent LipofectAMINE 2000 we have examined the delivery of plasmid DN...
Ex vivo gene therapy offers enormous potential for cell-based therapies, however, cumbersome in vitr...
Copyright © 2010 C. Madeira et al. This is an open access article distributed under the Creative Com...
Objective: Genetic modification of human embryonic stem cells (hESCs) is critical for their extensi...
Embryonic stem (ES) cells are derived from the inner cell mass of blastocysts, an early-stage of pre...
Abstract — Stem/progenitor cells hold a great promise for application in several therapies due to th...
[[abstract]]Embryonic stem (ES) cells are considered to have potentials for tissue regeneration and ...
The ability of embryonic stem cells and adult stem cells to differentiate into specific cell types h...
It is widely recognized that gain- and loss-of-function approaches are essential for understanding t...
Embryonic stem (ES) cells are considered to have potentials for tissue regeneration and treatment of...
Nucleic acids have clear clinical potential for gene therapy. Plasmid DNA (pDNA) was the first nucle...
Technologies designed to allow manipulation and modification of human embryonic stem (hES) cells are...
Electroporation has been the method of election for transfection of murine embryonic stem cells for ...
Ex vivo gene therapy offers enormous potential for cell-based therapies, however, cumbersome in vitr...
Low efficiency of transfection limits the ability to genetically manipulate human embryonic stem cel...
AbstractUsing the lipofection reagent LipofectAMINE 2000 we have examined the delivery of plasmid DN...
Ex vivo gene therapy offers enormous potential for cell-based therapies, however, cumbersome in vitr...
Copyright © 2010 C. Madeira et al. This is an open access article distributed under the Creative Com...
Objective: Genetic modification of human embryonic stem cells (hESCs) is critical for their extensi...
Embryonic stem (ES) cells are derived from the inner cell mass of blastocysts, an early-stage of pre...